Strategic Growth CardioFocus has recently expanded its pulsed field ablation programs and formed partnerships to develop robotic PFA systems, signaling opportunities to cross-sell complementary ablation navigation, robotic assistance, and integration solutions to hospitals adopting advanced PFA workflows.

Robotic Collaboration With partnerships with Stereotaxis for robotic PFA systems, there is a clear path to engage large electrophysiology centers already invested in robotics, offering turnkey integration, training, and service packages to accelerate adoption.

Clinical Validation Recent late-breaking data presentations at AF Symposium 2026 and ongoing PFA clinical programs create a compelling case for hospital procurement teams, enabling targeted outreach around outcomes, durability, and energy delivery optimization.

Acquisition Momentum The acquisition of Galvanize’s electrophysiology division strengthens CardioFocus’s product portfolio and customer base, presenting up-sell opportunities to existing customers for expanded catheter systems, mapping tools, and complementary EP technologies.

Global Expansion Pro ven EU availability of Centauri PFA platform and international development plans position CardioFocus as a candidate to approach multi-national hospitals and health systems seeking standardized PFA solutions with scalable support and training.